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 
Abstract— We aim at an analysis of the effects mechanical 
ventilators (MVs) and thoracic artificial lungs (TALs) will have 
on the cardiovascular system, especially on important 
quantities, such as left and right ventricular external work 
(EW), pressure-volume area (PVA) and cardiac mechanical 
efficiency (CME). Our analyses are based on simulation studies 
which were carried out by using our CARDIOSIM© software 
simulator. At first, we carried out simulation studies of patients 
undergoing mechanical ventilation (MV) without a thoracic 
artificial lung (TAL). Subsequently, we conducted simulation 
studies of patients who had been provided with a TAL, but did 
not undergo MV. We aimed at describing the patient’s 
physiological characteristics and their variations with time, 
such as EW, PVA, CME, cardiac output (CO) and mean 
pulmonary arterial/venous pressure (PAP/PVP). We were 
starting with a simulation run under well-defined initial 
conditions which was followed by simulation runs for a wide 
range of mean intrathoracic pressure settings. Our simulations 
of MV without TAL showed that for mean intrathoracic 
pressure settings from negative (-4 mmHg) to positive (+5 
mmHg) values, the left and right ventricular EW and PVA, 
right ventricular CME and CO decreased, whereas left 
ventricular CME and the PAP increased. The simulation 
studies of patients with a TAL, comprised all the usual TAL 
arrangements, viz. configurations “in series” and in parallel 
with the natural lung and, moreover, hybrid configurations. 
The main objective of the simulation studies was, as before, the 
assessment of the hemodynamic response to the application of a 
TAL. We could for instance show that, in case of an “in series” 
configuration, a reduction (an increase) in left (right) 
ventricular EW and PVA values occurred, whereas the best 
performance in terms of CO can be achieved in the case of an 
in parallel configuration.  
I. INTRODUCTION 
Mechanical ventilators (MVs) and thoracic artificial lungs 
(TALs) are being applied to assist patients affected by 
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respiratory failure. In the following, we will investigate 
specific aspects of their use in clinical practice.  
Mechanical Ventilation (MV).  Generally, the treatment 
with a ventilator is mandatory whenever a patient’s 
respiratory system becomes unable to keep the concentrations 
of O2 and CO2 in blood at tolerable levels. There exists a 
whole range of clinical applications of MV. Severe 
impairments of the lungs may occur in serious cases of 
chronic obstructive pulmonary disease (COPD), acute 
respiratory distress syndrome (ARDS), and in pneumonia. A 
ventilator may also be necessary for patients who need 
ventricular assist device (VAD) assistance [1]. MV of the 
respiratory system gives rise to specific interactions with 
other organs. These interactions may cause complications 
and other adverse effects. In particular, MV has a significant 
effect on the cardiovascular system [2]. We will focus here 
on these interactions and quantitatively describe the effects of 
MV on the cardiovascular system by carrying out simulation 
studies with our simulator CARDIOSIM
©
 which will be 
described in detail later. By using CARDIOSIM
©
, we 
simulated these interactions for different modes of operation. 
In particular, we determined specific energetic and 
hemodynamic quantities and parameters of the 
cardiovascular system influenced by MV, such as left and 
right ventricular external work (EW), pressure-volume area 
(PVA), cardiac mechanical efficiency (CME) [3], cardiac 
output (CO), and mean pulmonary arterial pressure. MVs are 
widely used. A whole variety of forms and types of these 
lung assist devices (LADs) exists. In the past, anesthetists 
have also made use of our simulation facilities to acquire data 
which allowed them to study and compare the performance 
capacities and especially the effects the ventilators will have 
on the cardiovascular system [4],[5]. 
Thoracic Artificial Lung (TAL).  TAL can be regarded 
as a viable alternative to MV. This lung assist device (LAD) 
is for instance advantageously used as an interim aid for 
patients who are waiting on a lung transplant, since, on the 
one hand, mechanical ventilation would be a contraindication 
for lung transplantation and, on the other hand, a TAL has the 
ability to either partially or totally fulfill the function of 
natural lungs. In the following, we will deal with simulation 
studies which we carried out by using our simulator 
CARDIOSIM
©
. We designed a special module for TAL 
[6],[7] and configured CARDIOSIM
©
 for our investigations 
in a straightforward manner by appropriately interconnecting 
the already existing individual software modules and the 
newly-developed module for the TAL. The TAL can be 
arranged either in parallel or “in series” with the natural lung. 
Moreover, a hybrid mode is also possible.  
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II. MATERIAL AND METHOD 
A. Numerical simulator 
We will aim again at characterizing the interactions 
between LAD and the cardiovascular system.  In doing so, 
we carried out simulation studies with our numerical 
simulator CARDIOSIM©. As already adumbrated above, 
CARDIOSIM© is hallmarked by its modular building 
principle. A library of lumped components (modules) has 
been created, the most important modules of them are:  
 Modules “Left Heart” and “Right Heart.” These 
(software) modules comprise mathematical models 
describing the behavior of the ventricles, the atria and the 
septa. For the ventricles, atria and the ventricular septum 
we used a variable elastance modeling approach, whereas 
we assumed that the atrial septum as being rigid [8],[9]. 
 Module “Systemic Arterial Section.” In our modeling 
approach, the systemic arterial section is described by three 
individual resistance-inertance-compliance (RLC) lumped 
elements AT, TT and ABT (Windkessel-like models [10]); 
AT describes the arterial, TT the thoracic and ABT the 
abdominal part of the systemic circulation (Fig. 1). 
 Modules “Systemic Venous Section” and “Pulmonary 
Venous Section.” Each of these venous sections is 
described by one resistance-compliance (RC) lumped 
element [11]. 
 Module “Main Pulmonary Artery Section.” This module 
describes the larger pulmonary arteries by one resistance-
inertance-compliance (RLC) lumped element (Windkessel-
like modeling approach [6],[7],[12]). 
 Module “Small Pulmonary Artery Section.” This module 
describes all the small intra-pulmonary arteries proximal to 
the arterioles by one resistance-inertance-compliance 
(RLC) lumped element (Windkessel-like modeling 
approach [7],[12]). 
 Module “Pulmonary Arterioles Section.” This section was 
modeled by only a single resistance, since the arterioles are 
relatively stiff, and, moreover, the inertial forces are 
negligible [7],[12]. 
 Module “Pulmonary Capillaries Section.” This section 
has justifiably also been modeled by a single resistance 
[7],[12]. 
 Module “Coronary Circulation.” This section was 
modeled as a lumped parameter model based on the 
intramyocardial pump concept. For a more detailed 
description, please refer to [10]. 
 Module “Thoracic Artificial Lung” This module is based 
on a lumped parameter modeling approach by using 
resistance - inertance - compliance (RLC) elements [6],[7]. 
Of particular importance are the resistances (variables) 
RTALan, RTALala and RTALpab. By appropriately assigning 
finite or infinite values (cut off) to them, we are able to 
configure the “Module TAL” for “in series”, parallel or 
hybrid mode of operation (Fig. 1). 
The modular building principle of CARDIOSIM© allows 
us to assemble a simulation system which is tailored to the 
given problem area simply by appropriately interconnecting 
these modules. Fig. 1 depicts the way of assembling the 
above-described modules for our simulation studies of the 
effects of the lung assist devices on the cardiovascular 
system. 
 
Figure 1.  Electric analogue of the cardiovascular system with TAL. AT, 
TT and ABT represent the aortic, thoracic and abdominal tract, respectively. 
SV (PV) is the systemic (pulmonary) venous section. MPA (SPA) is the 
main (small) pulmonary artery section. PA (PC) is the pulmonary arteriole 
(capillary) section. Pt is the mean intrathoracic pressure. RTALin (CTALin) is 
the inlet graft resistance (compliance) to the TAL. RTALala and RTALpab are 
two resistances used to divide the flow between the pulmonary circulation 
(RTALpab) and the left atrium (RTALala). RTALan is the outlet graft resistance to 
the pulmonary artery. 
 In Fig. 1 Pt is the mean intrathoracic pressure and it is 
defined as:  
           (1) 
where T is the duration of a ventilatory cycle and pt(t) an 
instantaneous value of the time-varying thoracic pressure.  
B. Experimental method 
As already mentioned earlier, our simulation studies 
comprise two kinds of studies, viz. (a) investigations of the 
interactions between MV (without TAL) and the 
cardiovascular system and (b) investigations of the 
interactions between the application of a TAL (without MV) 
and the cardiovascular system. In both kinds of 
investigations, there are methodological similarities and 
differences [13]: 
Similarities. In both kinds of investigations, we carried out 
several simulation runs, each for a distinct value of the 
varying quantity Pt. The results reveal the varying effect of 
the respiratory system on the cardiovascular system [5]. 
Particularities - MV without TAL. To assess the effect of 
MV on the cardiovascular system, we started with a 
simulation run at baseline conditions (Pt=0 mmHg); 
afterwards we carried out simulation runs for varying levels 
of Pt ranging from -4 mmHg to +5 mmHg in steps of 1 
mmHg.  
Particularities - TAL without MV. As before, we aim again 
at the effect this lung assist device will have on the 
cardiovascular system. Our simulation studies comprised 
  
TALs “in series”, parallel and hybrid mode of operation. 
Simulation runs were carried out for each mode of operation 
at two levels of Pt, viz. Pt=0 mmHg and Pt=-4 mmHg, which 
we will regard as being two different baseline conditions. The 
configuration of  TAL for the “in series” mode of operation is 
effected by assigning the infinite value (
resistances RTALpab and RTALala, whereas a
assigned to the resistance RTALan. In
configuration of TAL for the parallel mode
effected by assigning the infinite value (
resistance RTALan, whereas  finite values are
resistances RTALpab and RTALala. However, in
operation, finite values are given to all the
resistances RTALan, RTALpab and RTALala 
simulation studies comprised simulation ru
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Figure 2.  Percentage changes calculated respect to Pt=0 mmHg when the 
effects of MV was reproduced. The two upper panels show the percentage 
changes for the left and right ventricular energetic variables. The lower 
panel show the percentage changes of cardiac output (left panel) and  of 
PAP and PVP. 
This first series of simulations is based on the assumption 
that the applied TAL is modeled by using the module 









 (Fig. 1). 
The results are graphically represented in Fig. 3 as four 
column diagrams showing the values of the physiological 
parameters left EW (PVA) and right EW (PVA). The results 
of the first series of simulation runs refer to breathing without 









. The acquired 
hemodynamic parameters EW and PVA which are visualized 
as column diagrams in Fig. 3 will allow experienced 
clinicians and especially novices to attain an overview of the 
hemodynamic consequences of the application of a TAL. 
This first series of simulations was continued by a second and 
third series of simulation runs. These simulation runs have 
primarily been carried out to complement the knowledge 
which has already been derived from the first series of 
simulations, especially by studying to what extent deviations 
from the above values of RTALin= 20 g·cm-4·sec-1 and CTALin=
0.9 cm3·mmHg-1 will affect the hemodynamic parameters.  
In particular, the aim of the second series of simulation 
studies is to study the hemodynamic consequences a TAL 
will have on the left and right ventricular quantities EW and 
PVA, and, moreover, on the parameters CO and PAP in cases 
where the resistance RTALin deviated from its previously fixed 
value of RTALin=20 g·cm-4·sec-1, whereas the compliance 
CTALin=0.9 cm3·mmHg-1 remained unchanged. We carried out 
simulation runs for the wide range of RTALin from 2 to 700 
g·cm-4·sec-1. For each value of RTALin, the simulation runs 
involved all the three modes of operation (“in series”, 
parallel, and hybrid), and, as before, we confined the 
simulation runs to the two distinct values of the mean 




Figure 3.  Left and right ventricular EW and PVA without and with TAL 
assistance. The simulations were performed setting Pt=-4 and Pt=0 mmHg. 
TAL assistance was applied “in series”, in parallel and in hybrid mode.         
For each panel data were normalized to the maximum value. Inlet graft 
resistance and compliace were se to RTALin=20 [g.cm
-4·sec-1]  and CTALin=0.9 
[cm3·mmHg-1] 
Fig. 4 depicts the  variations of  the ventricular energetic 
parameters left EW (PVA) and right EW (PVA) with the 





, whereas the variations of the hemodynamic 
parameters CO and PAP with rising RTALin can be seen in 
Fig. 5 (diagrams in the lower row). In Figs. 4 and 5, the 
ordinate scales are percentage scales; in all diagrams the 
percentage expresses how large or small the values of the 
individual hemodynamic quantities (with TAL) are relative to 
the corresponding quantities in case of quiet breathing 
conditions without TAL (baseline conditions). It can be seen 
in Fig. 4 that, roughly speaking, the left (right) ventricular 
EW and PVA increase (decrease) with rising values of RTALin. 
Moreover, the values of left (right) ventricular EW and PVA 
for the “in series” mode of operation are essential higher than 
those in case of the parallel and hybrid mode. In contrast, the 
influence of the value of  Pt on the just mentioned quantities 
is almost insignificant. Fig. 5 (lower row of diagrams) shows 
that the hemodynamic parameter CO increases with rising 
values of RTALin; the influence of the value of Pt is again 
almost insignificant. The diagram in the lower right-hand 
corner of Fig. 5 shows that, roughly speaking, the mean PAP 
increases with rising RTALin if TAL is applied in “in series” 
mode. In the case of  parallel and hybrid mode both 
parameters, CO and PAP, are only changing insignificantly 





then decrease significantly for higher values of RTALin. Fig. 5 
(diagrams in the upper row) depicts the variations of the 
hemodynamic parameters CO and mean PAP with rising 
values of CTALin. In particular, the value of CO increases with 
rising values of CTALin if the TAL is applied in the “in series” 
mode of operation, whereas in this mode the values of mean 
PAP are barely changed.  
The third series of simulation runs aims at the 
hemodynamic consequences a TAL will have on the left and 
right ventricular quantities EW and PVA, and, moreover, on 
the parameters CO and PAP in cases where the compliance 










remained unchanged (Figs. 5 and 6). 
 
Figure 4.  Percentage changes of left and right ventricular EW and PVA. 
During the different simulations  CTALin was set to 0.9 [cm
3·mmHg-1]. The 
simulations were performed setting Pt=-4 and Pt=0 mmHg. TAL assistance 
was applied “in series”, in parallel and in hybrid mode.  
 
Figure 5.  Percentage changes of CO and mean PAP. The simulations were 
performed setting Pt=-4 and Pt=0 mmHg. TAL assistance was applied “in 
series”, in parallel and in hybrid mode. Percentage changes were calculated 
with respect to baseline conditions without TAL assistance. 
In particular, we carried out simulation runs for the wide 




. For each value 
of CTALin, the simulation runs involved all the three modes of 
operation (“in series”, parallel and hybrid), and, as before, we 
confined the simulation runs to the two distinct values of the 
mean intrathoracic pressure, viz. Pt=-4 mmHg and Pt=0 
mmHg. In Figs. 5 and 6, the ordinate scales are, as before, 
percentage scales. In these diagrams, the percentage 
expresses again how large or small the values of the 
individual hemodynamic quantities (with TAL) are relative to 
the corresponding quantities in case of quiet breathing 
conditions without TAL (baseline conditions). Fig. 6 depicts 



































































































ventricular EW and PVA with rising values of CTALin (range 






Figure 6.  Percentage changes of left and right ventricular EW and PVA. 
During the different simulations  RTALin was set to 20 [g·cm
-4·sec-1]. The 
simulations were performed setting Pt=-4 and Pt=0 mmHg. TAL assistance 
was applied “in series”, in parallel and in hybrid mode. Percentage changes 
were calculated with respect to baseline conditions without TAL assistance. 
In the case of “in series” mode of operation, the values of 
left ventricular EW and PVA increase with rising values of 
CTALin. Right ventricular EW and PVA increase (with respect 
to baseline conditions) even further when TAL assistance 
was applied in parallel and in hybrid mode. 
 
IV. CONCLUSIONS REMARKS AND FUTURE WORK 
We referred to patients with respiratory failure who will 
need technical devices to ensure that the concentrations of 
O2 and CO2 in the blood remain at tolerable levels. All kinds 
of respiratory assistance have severe consequences on other 
parts of the human body, especially on the circulation.  We 
investigated the influence of the respiratory support on the 
entire cardiovascular system by carrying out simulation 
studies with our newly-developed software simulator 
CARDIOSIM
©
. Unfortunately, the current status of our 
modeling approach does not sufficiently take into account 
the details of the complicated anatomic structure of the 
cardiovascular system; and, moreover, it does not describe 
the markedly nonlinear characteristics of the cardiovascular 
system; furthermore, the assumption of a uniform 
intrathoracic pressure must be regarded as being a 
considerable simplification. Hence, the simulation results 
attained with our model can only be regarded as relatively 
coarse approximations. Nonetheless, it proved that the 
results of our present simulation studies have provided 
clinicians with valuable insights on how to quantitatively 
assess the effects of assisted respiration on the 
cardiovascular system. Furthermore, CARDIOSIM
©
 
facilitated important clinical decision-making processes. 
Yet, we endeavor to improve our simulation modeling 
concept, primarily (a) by arranging for a more detailed 
description of the anatomy by using an essentially higher 
number of lumped components, (b) by taking in full account 
the nonlinear mechanical behavior of the vessel walls, and 
(c) by a more sophisticated characterization of the variations 
of the extramural pressure of the blood vessels throughout 
the human body (intrathoracic, intrapulmonary, and 
intraabdominal pressure). This future work will be done step 
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